Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Activating Mutations Affecting the Dbl Homology Domain of SOS2 Cause Noonan Syndrome
Viviana Cordeddu, Jiani C. Yin, Cecilia Gunnarsson, et al.
Human Mutation (2015) Vol. 36, Iss. 11, pp. 1080-1087
Open Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

The RASopathy Family: Consequences of Germline Activation of the RAS/MAPK Pathway
Mylène Tajan, Romain Paccoud, Sophie Branka, et al.
Endocrine Reviews (2018) Vol. 39, Iss. 5, pp. 676-700
Open Access | Times Cited: 196
The RASopathies: from pathogenetics to therapeutics
Katie E. Hebron, Edjay R. Hernandez, Marielle E. Yohe
Disease Models & Mechanisms (2022) Vol. 15, Iss. 2
Open Access | Times Cited: 117
Pathogenetics of the RASopathies
William E. Tidyman, Katherine A. Rauen
Human Molecular Genetics (2016) Vol. 25, Iss. R2, pp. R123-R132
Open Access | Times Cited: 112
Expansion of the RASopathies
William E. Tidyman, Katherine A. Rauen
Current Genetic Medicine Reports (2016) Vol. 4, Iss. 3, pp. 57-64
Open Access | Times Cited: 98
SOS GEFs in health and disease
Fernando C. Baltanás, Natasha Zarich, José M. Rojas, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1874, Iss. 2, pp. 188445-188445
Open Access | Times Cited: 71
Primary lymphoedema
Pascal Brouillard, Marlys H. Witte, Robert P. Erickson, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Closed Access | Times Cited: 62
The molecular genetics of RASopathies: An update on novel disease genes and new disorders
Marco Tartaglia, Yoko Aoki, Bruce D. Gelb
American Journal of Medical Genetics Part C Seminars in Medical Genetics (2022) Vol. 190, Iss. 4, pp. 425-439
Open Access | Times Cited: 43
The SOS1 Inhibitor MRTX0902 Blocks KRAS Activation and Demonstrates Antitumor Activity in Cancers Dependent on KRAS Nucleotide Loading
Niranjan Sudhakar, Larry Yan, Fadia Qiryaqos, et al.
Molecular Cancer Therapeutics (2024) Vol. 23, Iss. 10, pp. 1418-1430
Open Access | Times Cited: 9
Clinical Presentation and Natural History of Hypertrophic Cardiomyopathy in RASopathies
Giulio Calcagni, Rachele Adorisio, Simone Martinelli, et al.
Heart Failure Clinics (2018) Vol. 14, Iss. 2, pp. 225-235
Closed Access | Times Cited: 64
Activating Mutations of RRAS2 Are a Rare Cause of Noonan Syndrome
Yline Capri, Elisabetta Flex, Oliver H.F. Krumbach, et al.
The American Journal of Human Genetics (2019) Vol. 104, Iss. 6, pp. 1223-1232
Open Access | Times Cited: 64
Hypertrophic Cardiomyopathy in RASopathies
Michele Lioncino, Emanuele Monda, Federica Verrillo, et al.
Heart Failure Clinics (2021) Vol. 18, Iss. 1, pp. 19-29
Open Access | Times Cited: 53
Genotype‐cardiac phenotype correlations in a large single‐center cohort of patients affected by RASopathies: Clinical implications and literature review
Chiara Leoni, Rita Blandino, Angelica Bibiana Delogu, et al.
American Journal of Medical Genetics Part A (2021) Vol. 188, Iss. 2, pp. 431-445
Closed Access | Times Cited: 44
Cardiovascular disease in Noonan syndrome
Mary Ella Pierpont, M. Cristina Digilio
Current Opinion in Pediatrics (2018) Vol. 30, Iss. 5, pp. 601-608
Closed Access | Times Cited: 59
Targeting RAS oncogenesis with SOS1 inhibitors
R.C. Hillig, Benjamin Bader
Advances in cancer research (2022), pp. 169-203
Closed Access | Times Cited: 25
Genotype and phenotype spectrum of NRAS germline variants
Franziska Altmüller, Christina Lißewski, Débora Romeo Bertola, et al.
European Journal of Human Genetics (2017) Vol. 25, Iss. 7, pp. 823-831
Open Access | Times Cited: 47
Recent Advances in the Genetics of Fractures in Osteoporosis
Fjorda Koromani, Katerina Trajanoska, Fernando Rivadeneira, et al.
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 41
Cognitive Phenotype and Psychopathology in Noonan Syndrome Spectrum Disorders through Various Ras/MAPK Pathway Associated Gene Variants
Ellen Wingbermühle, Renée L. Roelofs, Wouter Oomens, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 16, pp. 4735-4735
Open Access | Times Cited: 19
The heart in RASopathies
Angelica Bibiana Delogu, Giuseppe Limongelli, Paolo Versacci, et al.
American Journal of Medical Genetics Part C Seminars in Medical Genetics (2022) Vol. 190, Iss. 4, pp. 440-451
Closed Access | Times Cited: 19
Genetic variants of SOS2, MAP2K1 and RASGRF2 in the RAS pathway genes predict survival of HBV-related hepatocellular carcinoma patients
Qiuling Lin, Moqin Qiu, Xueyan Wei, et al.
Archives of Toxicology (2023) Vol. 97, Iss. 6, pp. 1599-1611
Closed Access | Times Cited: 11
Testing for Noonan syndrome after increased nuchal translucency
Marwan Ali, Stephen T. Chasen, Mary E. Norton
Prenatal Diagnosis (2017) Vol. 37, Iss. 8, pp. 750-753
Closed Access | Times Cited: 39
Prioritization of genes involved in endothelial cell apoptosis by their implication in lymphedema using an analysis of associative gene networks with ANDSystem
Olga Saik, Vadim Nimaev, Dilovarkhuja Usmonov, et al.
BMC Medical Genomics (2019) Vol. 12, Iss. S2
Open Access | Times Cited: 30
Drosophila RASopathy models identify disease subtype differences and biomarkers of drug efficacy
Tirtha K. Das, Jared Gatto, Rupa Mirmira, et al.
iScience (2021) Vol. 24, Iss. 4, pp. 102306-102306
Open Access | Times Cited: 25
RASopathies – what they reveal about RAS/MAPK signaling in skeletal muscle development
Katherine A. Rauen, William E. Tidyman
Disease Models & Mechanisms (2024) Vol. 17, Iss. 6
Open Access | Times Cited: 3
Update on the Clinical and Molecular Characterization of Noonan Syndrome and Other RASopathies: A Retrospective Study and Systematic Review
G.J. Reynolds, Andrea Gazzin, Diana Carli, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3515-3515
Open Access
Anchorage-independent growth conditions reveal a differential SOS2 dependence for transformation and survival in RAS-mutant cancer cells
Erin Sheffels, Nancy E. Sealover, Patricia L. Theard, et al.
Small GTPases (2019) Vol. 12, Iss. 1, pp. 67-78
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top